Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02210832 · ClinicalTrials.gov registry record · NA
Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 257
- Enrollment target
NCT02210832 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 257 participants.
The verdict
NCT02210832, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
Study Summary
Investigators will examine whether adding financial incentives to current best practices for smoking cessation during pregnancy (i.e., referral to pregnancy-specific counseling using a telephone quit line) increases cessation rates and improves infant health. While more expensive upfront compared to best practices alone, the investigators hypothesize that this treatment approach will be economically justified by the later cost savings associated with more women quitting, having healthier babies, and needing less healthcare. It should also help to reduce the greater risk for health problems often seen among those who less well off economically.
Interventions
- BEHAVIORAL Best practices
- BEHAVIORAL financial incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2014-01-31 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02210832
The ClinicalTrials.gov registry entry for NCT02210832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Best practices is the first listed.
NCT02210832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02210832 about?
NCT02210832 is a clinical study titled "Financial Incentives for Smoking Cessation Among Disadvantaged Pregnant Women". Investigators will examine whether adding financial incentives to current best practices for smoking cessation during pregnancy (i.e., referral to pregnancy-specific counseling using a telephone quit line) increases cessation rates and improves infant health. While more expensive upfront compared to...
What is the current status of trial NCT02210832?
This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2014-01-31. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT02210832?
The interventions under investigation include: Best practices (BEHAVIORAL), financial incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT02210832?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.